Documentos relacionados

1. Variants of HCMV <i>UL18</i> Sequenced Directly from Clinical Specimens Associate with Antibody and T-Cell Responses to HCMV.
2. Natural Killer Cells: From Innate to Adaptive Features.
3. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
4. Non-specific immunoglobulin titres against cytomegalovirus: an alternative to hyperimmune presentation.
5. Genomic and geographical structure of human cytomegalovirus.
6. Cytomegalovirus infection and antibody protection of the developing placenta.
7. Requirements for immunoglobulin synthesis in leukocyte cultures exposed to human cytomegalovirus.
8. In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
9. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
10. Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection.